JPRN-UMIN000001343已完成2 期
Prospective study of high dose MTX with R-CHOP therapy for primary central nervous system lymphoma. - MR-CHOP therapy for PCNS
Hematology and Immunology, Kanazawa Medical University0 个研究点目标入组 10 人开始时间: 2008年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1, extra-CNS lesion 2, severe infectious disease 3, pre-treatment history for lymphoma 4, HIV+, HTLV1+, HBs-Ag+ 5, physician's decision of inappropriateness
研究者
相似试验
进行中（未招募）
2 期
Phase II study of R-CHOP and R-high-dose MTX therapy for IVLBCJPRN-jRCTs041180165Yamaguchi Motoko37
已完成
2 期
MR-CHOP therapy (high dose MTX with R-CHOP) for primary CNS lymphoma.JPRN-UMIN000020513Department of hematology and Immunology, Kanazawa Medical University20
招募中
不适用
A pilot study of systemic high dose methotrexate for intraocular lymphoma after intravitreal methotrexate to prevent the development of central nerve system lymphomaIntraocular lymphomaJPRN-UMIN000003921Tokyo Medical and Dental University, Department of Hematology10
已完成
3 期
Phase III Randomised Study of High Dose Methotrexate and 5-Fluouracil Combined with Epirubicin (FEMTX) versus No Treatment in Stage II-III Resected Gastric CancerCancerISRCTN71625775Pharmacia Ltd & Upjohn (UK)
已完成
3 期
Phase III Study of High-dose Methotrexate and Whole Brain Radiotherapy With or Without Concomitant and Adjuvant Temozolomide in Patients with Primary CNS Lymphoma (JCOG1114C, PCNSL-TMZ-P3)JPRN-UMIN000008535Japan Clinical Oncology Group (JCOG)130